Source: ERS Lung Science Conference 2020
Disease area: -



Rating:

Share or cite this content

Citations should be made in the following way:
Patricia Ogger (London, United Kingdom). Itaconate drives the resolution of pulmonary fibrosis. ERS Lung Science Conference 2020

Member's Comments

No comment yet.

Related content which might interest you: Itaconate controls the severit of pulmonary fibrosis Source: Virtual Congress 2020 – Reflections from the Lung Science 2020 conference Year: 2020 HSP47siRNA targeting to myofibroblasts attenuates bleomycin-induced pulmonary fibrosis Source: Annual Congress 2012 - Interstitial lung disease: from bench to bedside Year: 2012 VEGF gene transfer enhances fibrosis but improves pulmonary hemodynamics in experimental pulmonary fibrosis Source: Annual Congress 2008 - Animal models of pulmonary fibrosis: mechanisms and therapies Year: 2008 Titrated oxygen requirement and prognostication in idiopathic pulmonary fibrosis Source: Eur Respir J 2012; 39: 359-365 Year: 2012 Tranilast inhibits pulmonary fibrosis by suppressing TGFbeta-mediated extracellular matrix protein production Source: Annual Congress 2013 –Diffuse pulmonary fibrosis Year: 2013 Macitentan reduces progression of TGF-ß1-induced pulmonary fibrosis and pulmonary hypertension Source: Eur Respir J, 52 (2) 1701857; 10.1183/13993003.01857-2017 Year: 2018 The impact of emphysema in pulmonary fibrosis Source: Eur Respir Rev 2013; 22: 153-157 Year: 2013 Ectopic subpleural fat deposition in idiopathic pulmonary fibrosis correlates with radiographic extension of fibrosis Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view Year: 2013 17(R)-resolvinD1 improves MMP-9/TIMP-1 imbalance leading to amelioration of pulmonary fibrosis in mice Source: International Congress 2016 – ILD pathogenesis Year: 2016 αB-crystallin is involved in the process of pulmonary fibrosis Source: Annual Congress 2010 - Emerging mechanisms in lung injury Year: 2010 αB-crystallin is involved in the process of pulmonary fibrosis Source: Annual Congress 2011 - The ageing pulmonary interstitium Year: 2011 High expression of telomerase/endothelin-1 increase replication and activation of vascular myofibroblasts in usual interstitial pneumonia/idiopathic pulmonary fibrosis Source: Annual Congress 2010 - Pathogenesis of diffuse parenchymal lung disease Year: 2010 Nintedanib inhibits contractile activity of lung myofibroblasts in a cellular model of scleroderma associated pulmonary fibrosis Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis: from the bench to the bedside Year: 2018 Effects of flow-dependent and threshold PEP on lung functions in cystic fibrosis Source: Eur Respir J 2003; 22: Suppl. 45, 332s Year: 2003 Subtypes of pulmonary emphysema on HRCT affect prognosis on combined pulmonary fibrosis and emphysema in idiopathic pulmonary fibrosis Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view Year: 2013 17(R)-resolvin D1 attenuates bleomycin-induced lung fibrosis in mice Source: Annual Congress 2013 –Novel in vitro and animal models to study lung diseases Year: 2013 Modelling pulmonary fibrosis Source: Annual Congress 2012 - PG4 Experimental models for respiratory medicine: strengths and limitations Year: 2012 Diffuse pulmonary fibrosis and pulmonary emphysema associated with paradoxically normal spirometry Source: Eur Respir J 2006; 28: Suppl. 50, 100s Year: 2006